Fingerprint
Dive into the research topics of 'Modified HyperCVAD Versus Bortezomib-HyperCAD in Patients With Relapsed/Refractory Multiple Myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Modified HyperCVAD Versus Bortezomib-HyperCAD in Patients With Relapsed/Refractory Multiple Myeloma
Megan M. Saraceni, Emma Scott, Richard T. Maziarz, Matthew B. Siegel, Solange Bassale, Susie Jiing, Eva Medvedova
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations